KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Capital Leases (2016 - 2021)

Neogenomics filings provide 12 years of Capital Leases readings, the most recent being $71000.0 for Q4 2021.

  • On a quarterly basis, Capital Leases fell 92.66% to $71000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $71000.0, a 92.66% decrease, with the full-year FY2021 number at $71000.0, down 92.66% from a year prior.
  • Capital Leases hit $71000.0 in Q4 2021 for Neogenomics, down from $152000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $11.5 million in Q4 2018 to a low of $71000.0 in Q4 2021.
  • Median Capital Leases over the past 5 years was $4.3 million (2017), compared with a mean of $4.1 million.
  • Biggest five-year swings in Capital Leases: surged 96.02% in 2017 and later crashed 92.66% in 2021.
  • Neogenomics' Capital Leases stood at $10.5 million in 2017, then increased by 9.54% to $11.5 million in 2018, then crashed by 72.3% to $3.2 million in 2019, then tumbled by 69.77% to $967000.0 in 2020, then crashed by 92.66% to $71000.0 in 2021.
  • The last three reported values for Capital Leases were $71000.0 (Q4 2021), $152000.0 (Q3 2021), and $448000.0 (Q2 2021) per Business Quant data.